Croatia's national medicines regulator. New cancer medicines reach Croatia mostly through the EU's centralised procedure; HALMED handles national authorisations and safety monitoring.
HALMED, the Agency for Medicinal Products and Medical Devices (Agencija za lijekove i medicinske proizvode), regulates medicines and medical devices in Croatia, including marketing authorisation, inspection and pharmacovigilance, as its page listing its activities says. As an EU member, Croatia receives medicines with a new active substance for cancer through the European Medicines Agency's centralised procedure, which the EMA says is compulsory for them and valid in every member state; whether the Croatian Health Insurance Fund pays for them is a separate national decision. The coordinates on this record are an approximate Zagreb point.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Agency for Medicinal Products and Medical Devices of Croatia, including child institutions. 2 works · 1 citations · 100% open access · 0% clinical trials · 0% reviews.
| Work | Journal | Year | Citations |
|---|---|---|---|
| Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy. | Journal of Clinical Oncology | 2023 | 1 |
| Rhabdomyosarcoma of the Testicle in a young adult-Case Report 10.33425/2836-3647.1052 · open access | American Journal of Pathology & Research | 2026 | 0 |
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/